- Home
- ACRV vs HBB Comparison
ACRV vs HBB Comparison
Compare ACRV & HBB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- HBB
- Stock Information
- Founded
- ACRV 2018
- HBB 1904
- Country
- ACRV United States
- HBB United States
- Employees
- ACRV N/A
- HBB N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- HBB Home Furnishings
- Sector
- ACRV Health Care
- HBB Consumer Discretionary
- Exchange
- ACRV Nasdaq
- HBB Nasdaq
- Market Cap
- ACRV 247.8M
- HBB 292.6M
- IPO Year
- ACRV 2022
- HBB 2017
- Fundamental
- Price
- ACRV $6.44
- HBB $19.17
- Analyst Decision
- ACRV Strong Buy
- HBB
- Analyst Count
- ACRV 5
- HBB 0
- Target Price
- ACRV $22.40
- HBB N/A
- AVG Volume (30 Days)
- ACRV 46.9K
- HBB 67.9K
- Earning Date
- ACRV 11-13-2024
- HBB 10-30-2024
- Dividend Yield
- ACRV N/A
- HBB 2.38%
- EPS Growth
- ACRV N/A
- HBB 107.04
- EPS
- ACRV N/A
- HBB 1.88
- Revenue
- ACRV N/A
- HBB $647,834,000.00
- Revenue This Year
- ACRV N/A
- HBB $4.60
- Revenue Next Year
- ACRV N/A
- HBB N/A
- P/E Ratio
- ACRV N/A
- HBB $10.33
- Revenue Growth
- ACRV N/A
- HBB 5.30
- 52 Week Low
- ACRV $3.19
- HBB $13.92
- 52 Week High
- ACRV $11.90
- HBB $31.78
- Technical
- Relative Strength Index (RSI)
- ACRV 31.95
- HBB 25.34
- Support Level
- ACRV $6.11
- HBB $19.12
- Resistance Level
- ACRV $8.35
- HBB $21.02
- Average True Range (ATR)
- ACRV 0.48
- HBB 1.36
- MACD
- ACRV -0.23
- HBB -0.22
- Stochastic Oscillator
- ACRV 12.55
- HBB 0.65
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About HBB Hamilton Beach Brands Holding Company
Hamilton Beach Brands Holding Co, through its subsidiaries, is engaged in consumer, commercial, and specialty small appliances and specialty retail. It designs, markets, and distributes small branded electric household and specialty housewares small appliances, as well as commercial products for restaurants, bars, and hotels.